Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1500
+0.0040 (2.74%)
Aug 21, 2026, 4:08 PM HKT

Aceso Life Science Group Ratios and Metrics

Millions HKD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,3291,0543691,1741,314472
Market Cap Growth
757.14%185.60%-68.55%-10.67%178.13%-69.98%

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
3.933.12----
PS Ratio
-19.54-15.50-5.20106.706.352.78
PB Ratio
2.932.320.500.650.510.17
P/FCF Ratio
--24.61-6.921.82
P/OCF Ratio
--21.71-6.141.50

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
2.662.663.091.511.141.07
Debt / FCF Ratio
--153.40-15.3811.62
Net Debt / Equity Ratio
1.941.942.811.250.900.81
Net Debt / FCF Ratio
--139.27-47.2712.218.85
Quick Ratio
2.182.180.260.560.490.73
Current Ratio
2.282.280.280.570.700.93
Asset Turnover
---0.000.030.03
Return on Equity (ROE)
-71.62%-71.62%-79.55%-36.87%-7.70%-20.41%
Return on Assets (ROA)
-17.05%-17.05%-25.33%-14.59%-3.31%-9.59%
Return on Invested Capital (ROIC)
-9.03%-6.37%-7.64%-4.46%-1.59%-2.32%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
25.44%32.06%-242.49%-39.36%-20.09%-78.32%
FCF Yield
--4.06%-4.09%14.46%54.82%
Buyback Yield / Dilution
-3.38%-3.38%1.06%0.60%1.63%-6.06%